SM-17 is a humanized monoclonal antibody inhibitor that targets interleukin 25 (IL-25) and interleukin 17 receptor B (IL17RB). It holds potential for research in immune system disorders.
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted